Crossmark

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug

Crossref DOI link: https://doi.org/10.1016/j.pharep.2019.02.011

Published Print: 2019-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vásquez-Bochm, Luz X.

Velázquez-Paniagua, Mireya

Castro-Vázquez, Sandra S.

Guerrero-Rodríguez, Sandra L.

Mondragon-Peralta, Abimael

De La Fuente-Granada, Marisol

Pérez-Tapia, Sonia M.

González-Arenas, Aliesha

Velasco-Velázquez, Marco A. https://orcid.org/0000-0001-9717-0265
Funding

Funding for this research was provided by:

PAPIIT UNAM (IN228616)

CONACYT (INFR-2014-01-225313)

UDIMEB

CONACYT (294303)
License Information

Text and Data Mining valid from 2019-06-01
More Information

This article is maintained by: Elsevier

Article Title: Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2019.02.011

Content Type: article

Copyright: © 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.